United States · Growth startup
3 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$126Mraised across 3 rounds since 2003, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $86M sold, first sale Dec 2012
Reported by fis.dowjones.comSEC filing: $21M sold, first sale Jan 2011
OrbiMed
ABN AMRO FundFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
ACADIA Pharmaceuticals's investors include New Enterprise Associates, Venrock, OrbiMed, Oxford Bioscience Partners and ABN AMRO Fund, and 3 more on record.
ACADIA Pharmaceuticals has raised $126M across 3 rounds since 2003.
ACADIA Pharmaceuticals's most recent round was a Growth of $86M in Jan 2013.
Its most recent round, $86M in Jan 2013, is also its largest on record.
ACADIA Pharmaceuticals's first round on record, in Mar 2003, was backed by OrbiMed, Oxford Bioscience Partners and ABN AMRO Fund and 3 others.
ACADIA Pharmaceuticals's latest named round is a Growth, in Jan 2013.
ACADIA Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
